A two-part phase 1 study to establish and compare the safety and local tolerability of two nasal formulations of XF-73 for decolonisation of Staphylococcus aureus: A previously investigated 0.5mg/g viscosified gel formulation versus a modified formulation
一项分为两部分的 I 期研究,旨在确定并比较两种 XF-73 鼻腔制剂用于清除金黄色葡萄球菌的安全性和局部耐受性:一种是先前研究过的 0.5mg/g 粘稠凝胶制剂,另一种是改良制剂。
期刊:Journal of Global Antimicrobial Resistance
影响因子:3.2
doi:10.1016/j.jgar.2019.09.017
Yendewa, George A; Griffiss, J McLeod; Jacobs, Michael R; Fulton, Scott A; O'Riordan, Mary Ann; Gray, Wesley A; Proskin, Howard M; Winkle, Peter; Salata, Robert A